Toronto Dominion Bank’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$179K Buy
189,816
+16,616
+10% +$14K ﹤0.01% 1691
2026
Q1
$130K Buy
173,200
+124,158
+253% +$97.1K ﹤0.01% 1640
2025
Q4
$34.8K Sell
49,042
-958
-2% -$800 ﹤0.01% 1717
2025
Q3
$37.5K Sell
50,000
-7,794
-13% -$6.3K ﹤0.01% 1651
2025
Q2
$50.6K Buy
+57,794
New +$44.6K ﹤0.01% 1493

Other funds holding OACCW

Toronto Dominion Bank's OACCW Position: Q2 2026 in Review

Toronto Dominion Bank increased its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) stake by 9.6% in Q2 2026, buying an estimated $14K and bringing the position to 189,816 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

Toronto Dominion Bank first reported a position in OACCW in Q2 2025 and has held it in 5 quarters since. 27 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

  • Toronto Dominion Bank held 189,816 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $179K as of Q2 2026.
  • Toronto Dominion Bank bought 16,616 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q2 2026, an estimated $14K.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1691 holding.
  • Toronto Dominion Bank first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q2 2025 and has held it in 5 quarters since.
  • 27 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.